Crystallographic and molecular dynamics simulation analysis of Escherichia coli dihydroneopterin aldolase

Cell and Bioscience

Volumn 4, Issue 1, 2014, Pages

  Blaszczyk, Jaroslaw ^a,b,c   Lu, Zhenwei ^b,d   Li, Yue ^b   Yan, Honggao ^b   Ji, Xinhua ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Michigan State University   (United States)

^c CENTRE OF MOLECULAR AND MACROMOLECULAR STUDIES   (Poland)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Catalysis; DHNA; Dihydroneopterin aldolase; Dynamics; Structure

Indexed keywords

ESCHERICHIA COLI;

EID: 84910102644     PISSN: None     EISSN: 20453701     Source Type: Journal    
DOI: 10.1186/2045-3701-4-52     Document Type: Article

References (43)

1. Mathis JB, Brown GM. The biosynthesis of folic acid. XI. Purification and properties of dihydroneopterin aldolase. J Biol Chem 1970, 245:3015-3025.
2. Hauβmann C, Rohdich F, Schmidt E, Bacher A, Richter G. Biosynthesis of pteridines in Escherichia coli. Structural and mechanistic similarity of dihydroneopterin-triphosphate epimerase and dihydroneopterin aldolase. J Biol Chem 1998, 273:17418-17424. 10.1074/jbc.273.28.17418, 9651328.
3. Blakley RL, Benkovic SJ. Chemistry and Biochemistry of Folates. Folates and Pterins. Volume 1 1984, New York: John Wiley & Sons, Inc, Blakley RL, Benkovic SJ.
4. Hitchings GH, Burchall JJ. Inhibition of folate biosynthesis and function as a basis for chemotherapy. Adv Enzymol Relat Areas Mol Biol 1965, 27:417-468.
5. Walsh C. Where will new antibiotics come from?. Nat Rev Microbiol 2003, 1:65-70. 10.1038/nrmicro727, 15040181.
6. Bermingham A, Derrick JP. The folic acid biosynthesis pathway in bacteria: evaluation of potential for antibacterial drug discovery. Bioessays 2002, 24:637-648. 10.1002/bies.10114, 12111724.
7. Kompis IM, Islam K, Then RL. DNA and RNA synthesis: antifolates. Chem Rev 2005, 105:593-620. 10.1021/cr0301144, 15700958.
8. Nzila A. Inhibitors of de novo folate enzymes in Plasmodium falciparum. Drug Discov Today 2006, 11:939-944. 10.1016/j.drudis.2006.08.003, 16997145.
9. Nzila A. The past, present and future of antifolates in the treatment of Plasmodium falciparum infection. J Antimicrob Chemother 2006, 57:1043-1054. 10.1093/jac/dkl104, 16617066.
10. Zinner SH, Mayer KH. Sulfonamides and Trimethoprim. Principles and Practice of Infectious Diseases. Volume 1 2009, 475-485. Philadelphia: Churchill Livingstone, Mandell GL, Bennett JE, Dolin R, 6.
11. Wang Y, Li Y, Wu Y, Yan H. Mechanism of dihydroneopterin aldolase. NMR, equilibrium and transient kinetic studies of the Staphylococcus aureus and Escherichia coli enzymes. FEBS J 2007, 274:2240-2252. 10.1111/j.1742-4658.2007.05761.x, 17388809.
12. Wang Y, Li Y, Yan HG. Mechanism of dihydroneopterin aldolase: Functional roles of the conserved active site glutamate and lysine residues. Biochemistry 2006, 45:15232-15239. 10.1021/bi060949j, 3018710, 17176045.
13. Wang Y, Scherperel G, Roberts KD, Jones AD, Reid GE, Yan H. A point mutation converts dihydroneopterin aldolase to a cofactor-independent oxygenase. J Am Chem Soc 2006, 128:13216-13223. 10.1021/ja063455i, 17017801.
14. Hennig M, D'Arcy A, Hampele IC, Page MG, Oefner C, Dale GE. Crystal structure and reaction mechanism of 7,8-dihydroneopterin aldolase from Staphylococcus aureus. Nat Struct Biol 1998, 5:357-362. 10.1038/nsb0598-357, 9586996.
15. Sanders WJ, Nienaber VL, Lerner CG, McCall JO, Merrick SM, Swanson SJ, Harlan JE, Stoll VS, Stamper GF, Betz SF, Condroski KR, Meadows RP, Severin JM, Walter KA, Magdalinos P, Jakob CG, Wagner R, Beutel BA. Discovery of potent inhibitors of dihydroneopterin aldolase using CrystaLEAD high-throughput X-ray crystallographic screening and structure-directed lead optimization. J Med Chem 2004, 47:1709-1718. 10.1021/jm030497y, 15027862.
16. Blaszczyk J, Li Y, Gan J, Yan H, Ji X. Structural basis for the aldolase and epimerase activities of Staphylococcus aureus dihydroneopterin aldolase. J Mol Biol 2007, 368:161-169. 10.1016/j.jmb.2007.02.009, 1885205, 17331536.
17. Goulding CW, Apostol MI, Sawaya MR, Phillips M, Parseghian A, Eisenberg D. Regulation by oligomerization in a mycobacterial folate biosynthetic enzyme. J Mol Biol 2005, 349:61-72. 10.1016/j.jmb.2005.03.023, 15876368.
18. Garçon A, Levy C, Derrick JP. Crystal structure of the bifunctional dihydroneopterin aldolase/6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase from Streptococcus pneumoniae. J Mol Biol 2006, 360:644-653. 10.1016/j.jmb.2006.05.038, 16781731.
19. Bauer S, Schott AK, Illarionova V, Bacher A, Huber R, Fischer M. Biosynthesis of tetrahydrofolate in plants: crystal structure of 7,8-dihydroneopterin aldolase from Arabidopsis thaliana reveals a novel aldolase class. J Mol Biol 2004, 339:967-979. 10.1016/j.jmb.2004.04.034, 15165863.
20. Kraulis PJ. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J Appl Crystallogr 1991, 24:946-950.
21. Bacon DJ, Anderson WF. A fast algorithm for rendering space-filling molecule pictures. J Mol Graph 1988, 6:219-220.
22. Merritt EA, Bacon DJ. Raster3D: photorealistic molecular graphics. Methods Enzymol 1997, 277:505-524.
23. Yao LS, Yan HG, Cukier RI. Mechanism of dihydroneopterin aldolase: a molecular dynamics study of the apo enzyme and its product complex. J Phys Chem B 2006, 110:1443-1456. 10.1021/jp054854n, 16471696.
24. World Health Organization Report on Infectious Diseases: Removing Obstacles to Healthy Development 1999, Geneva: World Health Organization, World Health Organization.
25. Cohen ML. Changing patterns of infectious disease. Nature 2000, 406:762-767. 10.1038/35021206, 10963605.
26. Murray BE. Antibiotic resistance. Adv Intern Med 1997, 42:339-367.
27. Projan SJ. Why is big Pharma getting out of antibacterial drug discovery?. Curr Opin Microbiol 2003, 6:427-430. 10.1016/j.mib.2003.08.003, 14572532.
28. Spellberg B, Powers JH, Brass EP, Miller LG, Edwards JE. Trends in antimicrobial drug development: implications for the future. Clin Infect Dis 2004, 38:1279-1286. 10.1086/420937, 15127341.
29. Wenzel RP. The antibiotic pipeline-challenges, costs, and values. N Engl J Med 2004, 351:523-526. 10.1056/NEJMp048093, 15295041.
30. Barrett CT, Barrett JF. Antibacterials: are the new entries enough to deal with the emerging resistance problems?. Curr Opin Biotechnol 2003, 14:621-626. 10.1016/j.copbio.2003.10.003, 14662392.
31. Otwinowski Z, Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 1997, 276:307-326.
32. Brünger AT, Adams PD, Clore GM, DeLano WL, Gros P, Grosse-Kunstleve RW, Jiang JS, Kuszewski J, Nilges M, Pannu NS, Read RJ, Rice LM, Simonson T, Warren GL. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D 1998, 54:905-921.
33. Sheldrick GM, Schneider TR. SHELXL: high-resolution refinement. Methods Enzymol 1997, 277:319-343.
34. Jones TA, Kjeldgaard M. Electron-density map interpretation. Methods Enzymol 1997, 277:173-208.
35. Laskowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 1993, 26:283-291.
36. Vriend G. WHAT IF: a molecular modeling and drug design program. J Mol Graph 1990, 8:52-56. 29, 10.1016/0263-7855(90)80070-V, 2268628.
37. Case DA, Cheatham TE, Darden T, Gohlke H, Luo R, Merz KM, Onufriev A, Simmerling C, Wang B, Woods RJ. The Amber biomolecular simulation programs. J Comput Chem 2005, 26:1668-1688. 10.1002/jcc.20290, 1989667, 16200636.
38. Duan Y, Wu C, Chowdhury S, Lee MC, Xiong GM, Zhang W, Yang R, Cieplak P, Luo R, Lee T, Caldwell J, Wang JM, Kollman PA. A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J Comput Chem 2003, 24:1999-2012. 10.1002/jcc.10349, 14531054.
39. Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Montgomery JA, Vreven T, Kudin KN, Burant JC, Millam JM, Iyengar SS, Tomasi J, Barone V, Mennucci B, Cossi M, Scalmani G, Rega N, Petersson GA, Nakatsuji H, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, et al. Gaussian 03, Revision B.05 2003, Wallingford CT: Gaussian, Inc..
40. Ryckaert JP, Ciccotti G, Berendsen HJC. Numerical-integration of cartesian equations of motion of a system with constraints - molecular-dynamics of N-alkanes. J Comput Phys 1977, 23:327-341.
41. Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG. A smooth particle mesh Ewald method. J Chem Phys 1995, 103:8577-8593.
42. Berendsen HJC, Vanderspoel D, Vandrunen R. GROMACS - A message-passing parallel molecular-dynamics implementation. Comput Phys Commun 1995, 91:43-56.
43. Van der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJC. GROMACS: Fast, flexible, and free. J Comput Chem 2005, 26:1701-1718. 10.1002/jcc.20291, 16211538.